Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India

Bulletin of the World Health Organization

Volumn 85, Issue 2, 2007, Pages 138-145

  Sunish, I P ^a   Rajendran, R ^a   Mani, T R ^a   Munirathinam, A ^a   Dashb, A P ^b   Tyagi, B K ^a  

^a Centre for Research in Medical Entomology   (India)

^b NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; IVERMECTIN; POLYSTYRENE;

DISEASE PREVALENCE; DISEASE TRANSMISSION; DISEASE TREATMENT; DISEASE VECTOR; DRUG; EPIDEMIOLOGY; FILARIASIS; MOSQUITO; NEMATODE; VACCINATION;

ADOLESCENT; ARTICLE; CHILD; FILARIASIS; HUMAN; INDIA; INFECTION CONTROL; INSECT BITE; MASS SCREENING; MOSQUITO; PARASITE TRANSMISSION; PARASITE VECTOR; PREVALENCE;

ADOLESCENT; ADULT; ALBENDAZOLE; ANIMALS; ANTIPARASITIC AGENTS; CULEX; DIETHYLCARBAMAZINE; ELEPHANTIASIS, FILARIAL; ENDEMIC DISEASES; HUMANS; INDIA; INSECT VECTORS; IVERMECTIN; MOSQUITO CONTROL; POLYSTYRENES; PROGRAM EVALUATION; PUBLIC HEALTH PRACTICE; WATER SUPPLY; WUCHERERIA BANCROFTI;

ASIA; EURASIA; INDIA; SOUTH ASIA; TAMIL NADU; TIRUKOILUR; VILUPPURAM;

EID: 33846811370     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.06.029389     Document Type: Article

References (31)

1. Michael E, Bundy DA. Global mapping of lymphatic filariasis. Parasitol Today 1997;13:472-6.
2. Ottesen EA, Duke BO, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997;75:491-503.
3. Ottesen EA. The Global Programme to Eliminate Lymphatic Filariasis. Trop Med Int Health 2000;5:591-4.
4. Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, et al. Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med 2002;347:1841-8.
5. Curtis CF, Feachem RG. Sanitation and Culex pipiens mosquitoes: a brief review. J Trop Med Hyg 1981;84:17-25.
6. Jayasekera N, Kalpage KS, De Silva CS. The significance of low-density microfilaraemia in the transmission of Wuchereria bancrofti by Culex (Culex) quinquefasciatus Say in Sri Lanka. Trans R Soc Trop Med Hyg 1991;85:250-4.
7. Burkot T, Durrheim D, Melrose W, Speare R, Ichimori K. The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis. Filaria J 2006;5:10.
8. Maxwell CA, Curtis CF, Haji H, Kisumku S, Thalib AI, Yahya SA. Control of bancroftian filariasis by integrating therapy with vector control using polystyrene beads in wet pit latrines. Trans R Soc Trop Med Hyg 1990;84:709-14.
9. Sunish IP, Rajendran R, Mani TR, Munirathinam A, Tewari SC, Hiriyan J, et al. Resurgence in filarial transmission after withdrawal of mass drug administration and the interrelationship between antigenaemia and microfilaraemia - a longitudinal study. Trop Med Int Health 2002;7:59-69.
10. Reuben R, Rajendran R, Sunish IP, Mani TR, Tewari SC, Hiriyan J, et al. Annual single-dose diethylcarbamazine plus ivermectin for control of bancroftian filariasis: comparative efficacy with and without vector control. Ann Trop Med Parasitol 2001;95:361-78.
11. Rao CK, Sundaram RM, Venkatanarayana M, Rao JS, Chandrasekharan A, Rao CK. Epidemiological studies on bancroftian filariasis in East Godavari district (Andhra Pradesh): entomological aspects. J Commun Dis 1981;13:81-91.
12. Vollset SE. Confidence intervals for a binomial proportion. Stat Med 1993;12:809-24.
13. Pichon G, Prod'hon J, Riviere F. A distribution law for microfilaria ingested by mosquitoes biting human carriers. Preliminary results. [Article in French]. C R Acad Sci Hebd Seances Acad Sci D 1975;280:717-9.
14. Farid HA, Hammad RE, Hassan MM, Ramzy RM, El Setouhy M, Weil GJ. Effects of combined diethylcarbamazine and albendazole treatment of bancroftian filariasis on parasite uptake and development in Culex pipiens L. Am J Trop Med Hyg 2005;73:108-14.
15. Southgate BA, Bryan JH. Factors affecting transmission of Wuchereria bancrofti by anopheline mosquitoes. 4. Facilitation, limitation, proportionality and their epidemiological significance. Trans R Soc Trop Med Hyg 1992;86:523-30.
16. McGreevy PB, Kolstrup N, Tao J, McGreevy MM, Marshall TF. Ingestion and development of Wuchereria bancrofti in Culex quinquefasciatus, Anopheles gambiae and Aedes aegypti after feeding on humans with varying densities of microfilariae in Tanzania. Trans R Soc Trop Med Hyg 1982;76:288-96.
17. Pichon G. Limitation and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis. Ann Trop Med Parasitol 2002;96(Suppl 2):S143-52.
18. Maxwell CA, Mohammed K, Kisumku U, Curtis CF. Can vector control play a useful supplementary role against bancroftian filariasis? Bull World Health Organ 1999;77:138-43.
19. Esterre P, Plichart C, Sechan Y, Nguyen NL. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Trop Med Int Health 2001;6:190-5.
20. Tisch DJ, Hazlett FE, Kastens W, Alpers MP, Bockarie MJ, Kazura JW. Ecologic and biologic determinants of filarial antigenemia in bancroftian filariasis in Papua New Guinea. J Infect Dis 2001;184:898-904.
21. Chanteau S, Glaziou P, Luquiaud P, Plichart C, Moulia-Pelat JP, Cartel JL. Og4C3 circulating antigen, anti-Brugia malayi IgG and IgG4 titers in Wuchereria bancrofti infected patients, according to their parasitological status. Trop Med Parasitol 1994;45:255-7.
22. Nicolas L. New tools for diagnosis and monitoring of bancroftian filariasis parasitism: the Polynesian experience. Parasitol Today 1997;13:370-5.
23. Rajendran R, Sunish IP, Mani TR, Munirathinam A, Abdullah SM, Arunachalam N, et al. Impact of two annual single-dose mass drug administrations with diethylcarbamazine alone or in combination with albendazole on Wuchereria bancrofti microfilaraemia and antigenaemia in south India. Trans R Soc Trop Med Hyg 2004;98:174-81.
24. Tisch DJ, Michael E, Kazura JW. Mass chemotherapy options to control lymphatic filariasis: a systematic review. Lancet Infect Dis 2005;5:514-23.
25. Townson H, Nathan MB, Zaim M, Guillet P, Manqa L, Bos R, et al. Exploiting the potential of vector control for disease prevention. Bull World Health Organ 2005;83:942-7.
26. Sun DJ, Chen PL. Filariasis surveillance at the post-control stage in China. Southeast Asian J Trop Med Public Health 1992;23:369-76.
27. Cao W, Van der Ploeg CP, Ren Z, Habbema JD. Success against lymphatic filariasis. World Health Forum 1997;18:17-20.
28. Regis L, Furtado AF, Oliveira CM, Bezerra CB, Silva LR, Araujo J, et al. Integrated control of the filariasis vector with community participation in an urban area of Recife, Pernambuco, Brazil. [Article in Portugese] Cad Saude Publica 1996;12:473-82.
29. Curtis CF, Malecela-Lazaro M, Reuben R, Maxwell CA. Use of floating layers of polystyrene beads to control populations of the filaria vector Culex quinquefasciatus. Ann Trop Med Parasitol 2002;96(Suppl 2):S97-104.
30. Michael E, Malecela-Lazaro MN, Kabali C, Snow LC, Kazura JW. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions. Trends Parasitol 2006;22:226-33.
31. Ramaiah KD, Das PK, Dhanda V. Estimation of permissible levels of transmission of bancroftian filariasis based on same entomological parasitological results of a 5-year vector control programme. Acta Trop 1994;56:89-96.